Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion

NEW YORK (AP) — Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion.

Copyright © 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up